Understanding Your Weight Loss Treatment Options
Change from Wegovy to Mounjaro: Understanding Prescription Weight Loss Mechanisms
When considering whether to change from Wegovy to Mounjaro, understanding the fundamental differences between these prescription weight loss treatments is essential. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone, helping to reduce appetite and promote satiety after smaller meals. This prescription-only medicine works by targeting specific brain centres that control appetite, potentially reducing food cravings alongside a reduced-calorie diet and increased physical activity.
Mounjaro offers a different approach through tirzepatide, which acts as a dual receptor agonist targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. This dual mechanism may provide additional metabolic benefits beyond appetite control, though both treatments require the same commitment to lifestyle changes for optimal results. At EverydayMeds, our prescribers can help evaluate whether changing from Wegovy to Mounjaro aligns with your weight management goals, ensuring continuity of care throughout your treatment journey.
Wegovy Pricing and Value for Weight Management
Our transparent pricing structure makes accessing prescription weight loss treatment straightforward, with single Wegovy pens ranging from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance strength. New customers can apply code FIRST40 at checkout, while returning customers use DOSE25 to access these competitive prices. Our convenient bundle options include the Intro Duo (0.25mg & 0.5mg) for £169.99, providing the first two months of treatment in a single order, and the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99, covering three crucial escalation stages.
For those requiring maintenance therapy, our Ultimate Stability Trio provides three months of 2.4mg pens for £649.99, ensuring consistent supply without the need for frequent reordering. These bundles offer convenience and Confirmed Availability rather than cost savings, as maintaining your prescribed dosing schedule is crucial for treatment success. Whether you're starting your weight management journey or considering whether to change from Wegovy to Mounjaro, our flexible pricing accommodates various treatment paths and financial preferences.
Clinical Evidence Supporting Weight Loss Treatment Decisions
The STEP clinical trial programme provides robust evidence for Wegovy's effectiveness in weight management. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, as reported by Wilding et al. in the New England Journal of Medicine, 2021. STEP 5 demonstrated sustained weight loss of approximately 15.2% at two years, while the SELECT trial showed a 20% reduction in major cardiovascular events.
When considering whether to change from Wegovy to Mounjaro, it's important to note that direct comparison of trial results isn't appropriate due to different study designs and patient populations. Both treatments have demonstrated efficacy in their respective clinical programmes, and individual response can vary significantly. Our prescribers evaluate your treatment history, current response, and specific health profile to determine whether continuing with Wegovy or exploring alternatives like Mounjaro best serves your weight management objectives.
How Wegovy Works in Your Weight Management Programme
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines when you eat. This prescription-only medicine binds to GLP-1 receptors in your brain, particularly in areas that control appetite and food intake, potentially reducing feelings of hunger between meals. The medication may also slow gastric emptying, helping you feel fuller for longer after eating smaller portions. Additionally, Wegovy can influence reward pathways in the brain that are associated with food cravings, potentially making it easier to resist high-calorie foods. These combined mechanisms work alongside your reduced-calorie diet and increased physical activity to support sustainable weight management, with effects typically becoming apparent within the first few weeks of treatment.
Streamlined Ordering Process for Weight Loss Medications
Starting your prescription weight loss treatment with EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture all relevant medical history and current medications. Our qualified prescribers review each application within 3 working days (or 24 hours with express service), ensuring thorough evaluation of your suitability for treatment. Once approved, your Wegovy pens are dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all medications meet strict quality standards, with each order including detailed administration instructions and ongoing support. Whether you're beginning treatment or looking to change from Wegovy to Mounjaro, our streamlined process eliminates unnecessary delays while maintaining clinical safety standards.
Storage Requirements and Practical Considerations
Proper storage of Wegovy is crucial for maintaining medication effectiveness, with unused pens requiring refrigeration at 2-8°C until first use. Once removed from the fridge, Wegovy offers superior room temperature stability, remaining viable for up to 6 weeks below 30°C, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen design provides precise dosing with clear dose windows and audible clicks for injection confirmation. Dose escalation follows a mandatory schedule starting at 0.25mg for weeks 1-4, progressing through 0.5mg, 1mg, and 1.7mg stages before reaching the 2.4mg maintenance dose. This gradual increase helps minimise potential gastrointestinal side effects while allowing your body to adjust to the medication's effects throughout your weight management journey.
Making Informed Treatment Switches in Weight Management
The decision to change from Wegovy to Mounjaro involves careful consideration of your current treatment response, side effect profile, and individual weight management goals. Some patients explore switching due to plateau effects, where initial weight loss may stabilise after several months on the same treatment. Others may seek the dual receptor mechanism offered by Mounjaro's GIP/GLP-1 action, particularly if they have specific metabolic considerations beyond weight management.
At EverydayMeds, our prescribers evaluate multiple factors when patients wish to change from Wegovy to Mounjaro, including current weight loss progress, tolerance to treatment, and any comorbid conditions that might benefit from different mechanisms of action. Both treatments are prescription-only medicines requiring ongoing medical supervision, and transitioning between them should involve appropriate washout periods and dose considerations. Our clinical team provides continuity of care throughout any treatment changes, ensuring optimal outcomes regardless of which weight loss medication best suits your individual circumstances.
Complete Your Weight Loss Treatment Assessment Today
Both Wegovy and Mounjaro are available through EverydayMeds with the same convenient ordering process and expert clinical oversight to help determine which treatment aligns with your weight management objectives. New customers can access our services using code FIRST40 at checkout, while existing patients continue with DOSE25 for ongoing treatment. Our comprehensive clinical assessment takes just minutes to complete, with prescriber review ensuring appropriate treatment selection based on your individual medical profile and treatment history. Start your assessment today at https://everydaymeds.co.uk/collections/wegovy and take the next step in your weight management journey. Whether continuing with Wegovy or exploring alternatives like Mounjaro, our GPhC-registered pharmacy (#9012878) provides the clinical expertise and medication access you need for successful long-term weight management.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
